Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,000001 USD | 0,00% | -99,50% | 0,00% |
Vakgebied
Aantal werknemers: 39
Verkoop per activiteit
USD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Novel Anti-infective Agents
100,0
%
| 29 | 100,0 % | 37 | 100,0 % | +27,82% |
Verkoop per regio
USD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Austria, Ireland, and United States
100,0
%
| 29 | 100,0 % | 37 | 100,0 % | +27,82% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
H. Hogan
CEO | Chief Executive Officer | 61 | 07-07-23 |
Dave Maggio
DFI | Director of Finance/CFO | 64 | 30-06-23 |
Steven Gelone
BRD | Director/Board Member | 56 | 23-06-17 |
Director/Board Member | 69 | 24-07-18 | |
Kim Anderson
IRC | Investor Relations Contact | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Daniel Burgess
CHM | Chairman | 62 | 23-06-17 |
Director/Board Member | 69 | 24-07-18 | |
Stephen Webster
BRD | Director/Board Member | 63 | 01-08-16 |
Charles Rowland
BRD | Director/Board Member | 65 | 01-01-15 |
Steven Gelone
BRD | Director/Board Member | 56 | 23-06-17 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 3 230 837 | 3 200 138 ( 99,05 %) | 0 | 99,05 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
0,00% | 3 | |
+2,73% | 108 mld. | |
+9,59% | 104 mld. | |
+6,58% | 23,66 mld. | |
-12,59% | 22,1 mld. | |
-3,29% | 19,71 mld. | |
-35,36% | 18,2 mld. | |
-13,29% | 16,19 mld. | |
+4,68% | 13,72 mld. | |
+34,25% | 12,22 mld. |
- Beurs
- Aandelen
- Aandeel Nabriva Therapeutics plc - OTC Markets
- Onderneming Nabriva Therapeutics plc